The new drug was also developed in partnership with Sanofi and was approved in the US last year as Altuviio. “Children, adolescents, and adults can experience non-haemophilia factor VIII ...

Health Canada approved Altuviiio to treat hemophilia A in children, adolescents, and adults with the condition.